Tremor-reducing GyroGlove set to launch in 2017

Advances

Author: Parkinson's Life editorsPublished: 29 December 2016

Prep: Cook: Serves:

Inventors of GyroGlove announce plans to put the innovative ‘wearable’ into production in the coming year

The company behind GyroGlove has announced plans to bring the tremor-reducing device into production in 2017, following final testing and prototype development.

Founder Faii Ong, said: “We are in the midst of our last round of comprehensive modelling followed by prototyping for manufacture. After months of much grimacing, testing, caffeine and gnashing of teeth, the modelling results confirm all the live testing and data.”

GyroGlove is hi-tech glove that mechanically stabilises hands for people living with Parkinson’s. Further testing will begin in March 2017 and the company is calling for more volunteers to take part in the process.

Image credit: GyroGear

Sign up here to join the GyroCircle test volunteers group

Last Month

Next Month

Go Back

Share this story

Comments

Interviews

Capturing life with young onset Parkinson’s

We talk to UK photographer Paul Meyler

Ask the expert: How will Brexit affect Parkinson’s drugs and research?

Dr Kieran Breen on the supply and manufacture of medication

Could physical therapy be the future of specialised Parkinson’s care in Brazil?

Filling the physical therapy gaps in Brazil's healthcare system

New biotech to drive forward GDNF treatment for Parkinson’s disease

UK charity Parkinson’s UK is creating a new company, Vivifi Biotech, to develop a treatment with potential to stop or reverse Parkinson’s disease. The experimental therapy surgically distributes GDNF, a protein that is naturally produced by the brain to protect cells, directly into the brain. The charity previously funded a clinical trial to investigate whether boosting GDNF levels could regenerate dying brain cells in people with Parkinson’s. Over the next two years, it will invest up to £800,000 to prepare for a second trial. Arthur Roach, head of research at Parkinson’s UK, said: “While our initial trial didn’t meet its critical endpoint, it did reveal robust evidence indicating that GDNF can possibly reverse Parkinson’s. This is why Parkinson’s UK is committed to continuing research into this potential treatment.” Vivifi Biotech, Roach added, will “bring the right people together to plan a new trial that meets the needs of patients, regulatory…

New wearable medical device for Parkinson’s disease to launch this year

The Imperial College London Innovation Fund, UK, has invested £205,000 to support UK-based tech company Charco Neurotech in its development of a non-invasive medical device for people with Parkinson’s disease. CUE1, a circular device that attaches to the sternum with medical adhesives, uses specialised vibration to help alleviate physical symptoms of Parkinson’s disease. Initial user testing among people with the condition found that the device improved movement by an average of 16%, with testers reporting benefits for walking and fine motor tasks. Lucy Jung, CEO and co-founder of Charco Neurotech, said: “We believe that CUE1 has the potential to significantly improve [Parkinson’s disease] symptoms through its unique controlled vibration technology. We are excited to continue our work on the device and we look forward to the outcome of our proposed clinical trials.” Charco Neurotech will use the Imperial College investment to initiate a clinical trial and fund the device’s manufacture for…

New study brings scientists a “vital step” closer to understanding Parkinson’s disease

A new study from scientists at the University of Cambridge, UK, has brought researchers “a vital step” closer to discovering the origins of Parkinson’s disease. The research, published in the scientific journal ‘Nature Communications’, offered insights on the protein alpha-synuclein, which clumps together in the neurons of people with Parkinson’s. The study focused on how the protein functions in those without the condition and revealed that it sticks to the inner side of the plasma membrane of nerve cells, but not the outer membrane – an insight that could help in the search for a cure. Lead study author, Dr Giuliana Fusco, said: “This study could unlock more information about this debilitating neurodegenerative disorder that can leave people unable to walk and talk. If we want to cure Parkinson’s, first we need to understand the function of alpha-synuclein, a protein present in everyone’s brains.”

All fields required

First name*
Last name*
Email address*
Enter Email Confirm Email
Country of residence*
About me*
- I have Parkinson's disease
- I am a partner / carer / family / friend of someone who has Parkinson's
- I am a healthcare professional with an interest in Parkinson's
- I work for a Parkinson's disease organisation
- Other
CAPTCHA
*
- By proceeding you agree to our
Comments
This field is for validation purposes and should be left unchanged.

Tremor-reducing GyroGlove set to launch in 2017

Advances

Author: Parkinson's Life editorsPublished: 29 December 2016

Prep: Cook: Serves:

Last Month

Next Month

Share this story

Comments

Interviews

Capturing life with young onset Parkinson’s

Special reports

Ask the expert: How will Brexit affect Parkinson’s drugs and research?

In my country

Could physical therapy be the future of specialised Parkinson’s care in Brazil?

New biotech to drive forward GDNF treatment for Parkinson’s disease

New wearable medical device for Parkinson’s disease to launch this year

New study brings scientists a “vital step” closer to understanding Parkinson’s disease

{title}

Subscribe

Tremor-reducing GyroGlove set to launch in 2017

Advances

Author: Parkinson's Life editorsPublished: 29 December 2016

Prep: Cook: Serves:

Last Month

Next Month

Share this story

Comments

Related articles

Interviews

Capturing life with young onset Parkinson’s

Special reports

Ask the expert: How will Brexit affect Parkinson’s drugs and research?

In my country

Could physical therapy be the future of specialised Parkinson’s care in Brazil?

New biotech to drive forward GDNF treatment for Parkinson’s disease

New wearable medical device for Parkinson’s disease to launch this year

New study brings scientists a “vital step” closer to understanding Parkinson’s disease

{title}

Subscribe

Sign in